The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer

• Young Kwang Chae ,

  * E-mail: young.chae@northwestern.edu

  Affiliations Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America, Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Chicago, IL, United States of America, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States of America, Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America

  ⨯
• Debora de Melo Gagliato,

  Affiliations Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America, Department of Clinical Oncology, Hospital Sirio Libanes, São Paulo, SP, Brazil, Instituto de Cancer do Estado de São Paulo (ICESP), São Paulo, SP, Brazil

  ⨯
• Sachin Gopalkrishna Pai,

  Affiliations Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Chicago, IL, United States of America, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States of America, Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America

  ⨯
• Benedito Carneiro,

  Affiliations Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Chicago, IL, United States of America, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States of America, Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America

  ⨯
• Nisha Mohindra,

  Affiliations Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States of America, Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America

  ⨯
• Francis Joseph Giles,

  Affiliations Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Chicago, IL, United States of America, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States of America, Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America

  ⨯
• Praveen Ramakrishnan-Geethakumari,

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Joohyuk Sohn,

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Shuying Liu,

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Huiqin Chen,

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Naoto Ueno,

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Gabriel Hortobagyi,

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Ana Maria Gonzalez-Angulo

  Affiliation Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America

  ⨯